What is the address of JC GASTMED?

The registered office of JC GASTMED is located at Shetlanderdreef 10 box 9, 1150 Sint-Pieters-Woluwe.

Is JC GASTMED still active?

Yes. According to the CBE (29 October 2026) JC GASTMED is active, legal situation “Normale toestand”, started on 29 October 2021.

Is JC GASTMED registered on Peppol?

Yes, JC GASTMED is registered on the Peppol network with ID 0208:0776663459.

What is the enterprise number of JC GASTMED?

The enterprise number of JC GASTMED is BE0776663459.

When was JC GASTMED founded?

JC GASTMED was founded on 29 October 2021.

Who are the directors of JC GASTMED?

According to the 2025 annual accounts, the directors of JC GASTMED are: Joana Castela.

Is JC GASTMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 October 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JC GASTMED make in 2025?

JC GASTMED posted a profit after taxes of € 124,382 in financial year 2025.

What is the revenue of JC GASTMED?

As a small company, JC GASTMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 175,259.

JC GASTMED (Private Limited) - Sint-Pieters-Woluwe

Dossier JC GASTMED, printed on 29 October 2026 from databakkes.be/en/0776663459/jc-gastmed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JC GASTMED from Sint-Pieters-Woluwe, company number BE0776663459, closed financial year 2025 with a result of € 124,382 after tax. For that financial year JC GASTMED recorded a gross margin of € 175,259 and equity of € 331,986. Compared with financial year 2024, the result moved from € 95,081 to € 124,382. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 331,986

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 124,382

▲ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 198,011

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

96 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 1,325

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 293

▼ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,871

▼ 91% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 151,710 Gross margin 2022: € 151,710 First fiscal year in the series	€ 202,765 Gross margin 2023: € 202,765 ▲ 34% vs 2022 (€ 151,710) Favourable step	€ 132,189 Gross margin 2024: € 132,189 ▼ 35% vs 2023 (€ 202,765) Unfavourable step	€ 175,259 Gross margin 2025: € 175,259 ▲ 33% vs 2024 (€ 132,189) Favourable step	▲ 33%
Profit after taxes	€ 108,411 Profit after taxes 2022: € 108,411 First fiscal year in the series	€ 136,827 Profit after taxes 2023: € 136,827 ▲ 26% vs 2022 (€ 108,411) Favourable step	€ 95,081 Profit after taxes 2024: € 95,081 ▼ 31% vs 2023 (€ 136,827) Unfavourable step	€ 124,382 Profit after taxes 2025: € 124,382 ▲ 31% vs 2024 (€ 95,081) Favourable step	▲ 31%
Equity	€ 111,411 Equity 2022: € 111,411 First fiscal year in the series	€ 232,523 Equity 2023: € 232,523 ▲ 109% vs 2022 (€ 111,411) Favourable step	€ 327,604 Equity 2024: € 327,604 ▲ 41% vs 2023 (€ 232,523) Favourable step	€ 331,986 Equity 2025: € 331,986 ▲ 1% vs 2024 (€ 327,604) Favourable step	▲ 1%
Total debts	€ 36,522 Total debts 2022: € 36,522 First fiscal year in the series	€ 77,354 Total debts 2023: € 77,354 ▲ 112% vs 2022 (€ 36,522) Unfavourable step	€ 32,579 Total debts 2024: € 32,579 ▼ 58% vs 2023 (€ 77,354) Favourable step	€ 104,459 Total debts 2025: € 104,459 ▲ 221% vs 2024 (€ 32,579) Unfavourable step	▲ 221%
Cash	€ 93,160 Cash 2022: € 93,160 First fiscal year in the series	€ 238,650 Cash 2023: € 238,650 ▲ 156% vs 2022 (€ 93,160) Favourable step	€ 215,223 Cash 2024: € 215,223 ▼ 10% vs 2023 (€ 238,650) Unfavourable step	€ 198,011 Cash 2025: € 198,011 ▼ 8% vs 2024 (€ 215,223) Unfavourable step	▼ 8%
Retained profit	€ 108,411 Retained profit 2022: € 108,411 First fiscal year in the series	€ 229,523 Retained profit 2023: € 229,523 ▲ 112% vs 2022 (€ 108,411) Favourable step	€ 324,604 Retained profit 2024: € 324,604 ▲ 41% vs 2023 (€ 229,523) Favourable step	€ 328,986 Retained profit 2025: € 328,986 ▲ 1% vs 2024 (€ 324,604) Favourable step	▲ 1%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 15,715 Dividend 2023: € 15,715 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 15,715) Unchanged	€ 120,000 Dividend 2025: € 120,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 147,933 Balance sheet total 2022: € 147,933 First fiscal year in the series	€ 309,877 Balance sheet total 2023: € 309,877 ▲ 109% vs 2022 (€ 147,933) Unchanged	€ 360,183 Balance sheet total 2024: € 360,183 ▲ 16% vs 2023 (€ 309,877) Unchanged	€ 436,445 Balance sheet total 2025: € 436,445 ▲ 21% vs 2024 (€ 360,183) Unchanged	▲ 21%

Key figures of JC GASTMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JC GASTMED?

What happened at JC GASTMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 124,382 (▲ 31% vs 2024). Source: NBB ↗
Oct 29, 2021 New establishment in Sint-Pieters-Woluwe. KBO
Oct 29, 2021 Start of the company according to the CBE. KBO

In short

From € 108,411 profit in 2022 to € 124,382 profit in 2025.

Paid € 168,232 in corporate taxes since 2022.

Best year ever: 2023, with € 136,827 profit.

Paid out € 135,715 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Joana Castela

JC GASTMED

Behind JC GASTMED is Joana Castela.

Directors

According to the 2025 annual accounts

Joana Castela

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Shetlanderdreef 10 box 9

1150 Sint-Pieters-Woluwe

2.327.722.460

Grote Prijzenlaan 174 box 11

1150 Sint-Pieters-Woluwe

Active since 29 October 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

LILINVEST

€ 673 gross margin · 2024

Association des copropriétaires Complexe Alezan Balzan Tobiano, Woluwe-Saint-Pierre, avenues des Grands Prix, de Meurers, du Haras, de Biolley et Saint-Alix

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0776.663.459
VAT number: BE 0776.663.459
Registered office: Shetlanderdreef 10 bus 9, 1150 Sint-Pieters-Woluwe
Names & denominations: JC GASTMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 October 2021
Peppol: Active · Active since 29 Oct 2024

View on CBE Public ↗ Annual accounts (NBB) ↗